Literature DB >> 15254556

Kernicterus: epidemiological strategies for its prevention through systems-based approaches.

Vinod K Bhutani1, Lois H Johnson, M Jeffrey Maisels, Thomas B Newman, Ciaran Phibbs, Ann R Stark, Marshalyn Yeargin-Allsopp.   

Abstract

Kernicterus, thought to be due to severe hyperbilirubinemia, is an uncommon disorder with tragic consequences, especially when it affects healthy term and near-term infants. Early identification, prevention and treatment of severe hyperbilirubinemia should make kernicterus a preventable disease. However, national epidemiologic data are needed to monitor any preventive strategies. Recommendations are provided to obtain prospective data on the prevalence and incidence of severe hyperbilirubinemia and associate mortality and neurologic injury using standardized definitions, explore the clinical characteristics and root causes of kernicterus in children identified in the Kernicterus Pilot Registry, identify and test an indicator for population surveillance, validating systems-based approaches to the management of newborn jaundice, and explore the feasibility of using biologic or genetic markers to identify infants at risk for hyperbilirubinemia. Increased knowledge about the incidence and consequences of severe hyperbilirubinemia is essential to the planning, implementation and assessment of interventions to ensure that infants discharged as healthy from their birth hospitals have a safer transition to home, avoiding morbidity due to hyperbilirubinemia and other disorders. At a recent NIHCD-sponsored conference, key questions were raised about kernicterus and the need for additional strategies for its prevention. These questions and an approach to their answers form the basis of this report.

Entities:  

Mesh:

Year:  2004        PMID: 15254556     DOI: 10.1038/sj.jp.7211152

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  38 in total

1.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Authors:  Michael Kaplan; Cathy Hammerman; Hendrik J Vreman; Ronald J Wong; David K Stevenson
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

2.  Assessment of G6PD screening program in premature infants in a NICU.

Authors:  R Lam; H Li; M L Nock
Journal:  J Perinatol       Date:  2015-10-22       Impact factor: 2.521

Review 3.  Kernicterus as a 'Never-Event': a newborn safety standard?

Authors:  Vinod K Bhutani
Journal:  Indian J Pediatr       Date:  2005-01       Impact factor: 1.967

4.  Surveillance of severe neonatal hyperbilirubinemia: a view from south of the border.

Authors:  M Jeffrey Maisels; Thomas B Newman
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

Review 5.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.

Authors:  Kevin A Strauss; Charles E Ahlfors; Kyle Soltys; George V Mazareigos; Millie Young; Lauren E Bowser; Michael D Fox; James E Squires; Patrick McKiernan; Karlla W Brigatti; Erik G Puffenberger; Vincent J Carson; Hendrik J Vreman
Journal:  Hepatology       Date:  2020-02-05       Impact factor: 17.425

Review 7.  Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification.

Authors:  Yassar H Arain; Vinod K Bhutani
Journal:  Indian J Pediatr       Date:  2014-04-26       Impact factor: 1.967

8.  Quantitative ADC in bilirubin encephalopathy.

Authors:  Jon F Watchko; Michael J Painter; Ashok Panigrahy
Journal:  Jpn J Radiol       Date:  2013-02-02       Impact factor: 2.374

Review 9.  Cotrimoxazole and neonatal kernicterus: a review.

Authors:  Baskaran Thyagarajan; Sharad S Deshpande
Journal:  Drug Chem Toxicol       Date:  2013-10-07       Impact factor: 3.356

10.  Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland.

Authors:  Donal Manning; Peter Todd; Melanie Maxwell; Mary Jane Platt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-10-30       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.